Hemoterapia Brasil S.A.’s Acquisition of Fujisan Centro de Hemoterapia and Hematología del Ceará


Demarest and R. Amaral Advogados advised on the deal

Hemoterapia Brasil S.A. executed the acquisition of 100 % stake in Fujisan and Hematología del Ceará.

Contestually Fujisan sharesholder acquired 15,44 % interest in H. Hemo.

H Hemo – Hemoterapia Brasil S.A. is based in São Paulo, Brazil.

Demarest Advogados advised Hemoterapia Brasil S.A. (H.Hemo) with Joyl Gondim de Alencar Filho (Picture) and José Roberto Silva Jr.

R. Amaral Advogados advised Fujisan Centro de Hemoterapia and Hematología del Ceará with a team including Laerte Meyer de Castro Alves and Ilo Igo de Lima Marques.

Involved fees earner: Laerte Meyer de Castro Alves – R. Amaral Advogados; Ilo Igo de Lima Marques – R. Amaral Advogados; Joyl Gondim de Alencar Filho – Demarest; José Roberto Rodrigues da Silva Jr. – Demarest;

Law Firms: R. Amaral Advogados; Demarest;

Clients: Hemoterapia Brasil S.A.; Fujisan Centro de Hemoterapia; Hematología del Ceará;